Factors That Are Associated With Parental Acceptance of Human Papillomavirus Vaccines: A Randomized Intervention Study of Written Information About HPV

OBJECTIVES. Prophylactic vaccines against human papillomavirus (HPV) are expected to be available for public use by 2007 and likely will be targeted to preadolescent children. Parental acceptance of these vaccines will be critical for their success. The objectives of this study were (1) to determine the overall acceptance of HPV vaccines for preadolescent children by parents, (2) to evaluate the influence of written educational information about HPV on parental acceptability of HPV vaccines, and (3) to identify independent predictors associated with HPV vaccine acceptability by parents. METHODS. A randomized intervention study within a cross-sectional survey was conducted. Parental HPV vaccine acceptability was measured under 3 different hypothetical scenarios. A self-administered survey on the knowledge, attitudes, and beliefs about HPV and HPV vaccines was sent to 1600 parents of 8- to 12-year-old children. In addition to a baseline paragraph about HPV that was received by all study participants, a random half of the study participants received a detailed “HPV Information Sheet” outlining the epidemiology and potential clinical sequelae of HPV infection. Independent predictors of parental HPV vaccine acceptability were determined using multivariate linear regression models. RESULTS. Parents who received the HPV information sheet had higher mean scores on the HPV knowledge assessment tool than the control group. However, despite this apparent improvement in knowledge, there was not a statistically significant difference in HPV vaccine acceptability between the 2 groups. CONCLUSIONS. Providing parents with an HPV information sheet did seem to improve knowledge about HPV, but this increased knowledge had little effect on the acceptability of these vaccines by parents for their children. Instead, attitudes and life experiences seemed to be more important factors influencing HPV vaccine acceptability among parents.

[1]  Helen Trottier,et al.  The epidemiology of genital human papillomavirus infection. , 2006, Vaccine.

[2]  Howard Bauchner,et al.  Parental acceptance of the human papillomavirus vaccine. , 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[3]  S. Vermund,et al.  Parents'/guardians' willingness to vaccinate their children against genital herpes. , 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[4]  G. Zimet,et al.  Predictors of STI vaccine acceptability among parents and their adolescent children. , 2005, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[5]  S. Wacholder,et al.  Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. , 2005, The Journal of infectious diseases.

[6]  M. Farid,et al.  Psychological disturbance in graves ophthalmopathy. , 2005, Archives of ophthalmology.

[7]  G. Zimet,et al.  Parental attitudes about sexually transmitted infection vaccination for their adolescent children. , 2005, Archives of pediatrics & adolescent medicine.

[8]  P. White,et al.  Altered body image: appearance-related concerns of people with visible disfigurement. , 2004, Journal of advanced nursing.

[9]  Daron G Ferris,et al.  Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial , 2004, The Lancet.

[10]  D. Ferris,et al.  Human Papillomavirus Vaccine Acceptability Among Parents of 10- to 15-Year-Old Adolescents , 2004, Journal of lower genital tract disease.

[11]  G. Zimet,et al.  Parental perspectives on vaccinating children against sexually transmitted infections. , 2004, Social science & medicine.

[12]  C. Wheeler,et al.  A controlled trial of a human papillomavirus type 16 vaccine. , 2002, The New England journal of medicine.

[13]  W. Reeves,et al.  Seroprevalence of human papillomavirus type 16 infection in the United States. , 2002, The Journal of infectious diseases.

[14]  Jonathan A. Smith,et al.  Living with vitiligo: dealing with difference. , 2002, British journal of health psychology.

[15]  C. Peyton,et al.  Determinants of genital human papillomavirus detection in a US population. , 2001, The Journal of infectious diseases.

[16]  N. Muñoz,et al.  Acceptability of a human papillomavirus (HPV) trial vaccine among mothers of adolescents in Cuernavaca, Mexico. , 2001, Archives of medical research.

[17]  R. Jacobson,et al.  Understanding those who do not understand: a brief review of the anti-vaccine movement. , 2001, Vaccine.

[18]  J. Fortenberry,et al.  Vaccine characteristics and acceptability of HIV immunization among adolescents , 2000, International journal of STD & AIDS.

[19]  G. Freed,et al.  Parental knowledge, attitudes, and demand regarding a vaccine to prevent varicella. , 1999, American journal of preventive medicine.

[20]  W. Cates,et al.  Estimates of the Incidence and Prevalence of Sexually Transmitted Diseases in the United States , 1999 .

[21]  G. Zimet,et al.  Acceptability of Genital Herpes Immunization: The Role of Health Beliefs and Health Behaviors , 1997, Sexually transmitted diseases.

[22]  P. Succop,et al.  Hepatitis B vaccine acceptance among adolescents and their parents. , 1995, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[23]  V. Moreno,et al.  Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective , 1995 .

[24]  I. Krantz,et al.  Physical and Psychological Effects of Anogenital Warts on Female Patients , 1993, Sexually transmitted diseases.

[25]  C. Schofield Sexually transmitted disease surveillance. , 1982, British medical journal.

[26]  Daron G Ferris,et al.  Efficacy of a bivalent L 1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women : a randomised controlled trial , 2005 .

[27]  V. Moreno,et al.  Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. , 1995, Journal of the National Cancer Institute.

[28]  K. Glanz,et al.  Health Behavior and Health Education , 1990 .

[29]  Évin,et al.  A CONTROLLED TRIAL OF A HUMAN PAPILLOMAVIRUS TYPE 16 VACCINE , 2022 .